Page 930«..1020..929930931932..940950..»

A Heart Attack? No, It Was the Coronavirus – The New York Times

Posted: Published on March 29th, 2020

Cardiologists are seeing infected patients whose worst symptoms are not respiratory, but cardiac. The 64-year-old patient arrived at a hospital in Brooklyn with symptoms looking like those seen in patients having a serious heart attack. An electrocardiogram revealed an ominous heart rhythm Continue reading

Posted in Coronary Heart Diseases | Comments Off on A Heart Attack? No, It Was the Coronavirus – The New York Times

Heart disease and COVID-19: What you need to know – Chicago Daily Herald

Posted: Published on March 29th, 2020

Editor's note: The following Q&A was supplied by Northwestern Medicine. Answers are provided by Dr. Clyde Yancy, chief of cardiology, Northwestern Medicine Bluhm Cardiovascular Institute, and Dr. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Heart disease and COVID-19: What you need to know – Chicago Daily Herald

COVID-19: Reconfiguration of Cardiac Services and Delivery of Cardiovascular Care – Medscape

Posted: Published on March 29th, 2020

This transcript has been edited for clarity. Hi, welcome to Medscape UK Continue reading

Posted in Coronary Heart Diseases | Comments Off on COVID-19: Reconfiguration of Cardiac Services and Delivery of Cardiovascular Care – Medscape

Covid-19 shutdown: Health expert says plan B needed for people with chronic conditions – Malay Mail

Posted: Published on March 29th, 2020

People are seen wearing face masks to protect themselves against the new coronavirus in Kuala Lumpur. Continue reading

Posted in Coronary Heart Diseases | Comments Off on Covid-19 shutdown: Health expert says plan B needed for people with chronic conditions – Malay Mail

People with diabetes are at high risk for coronavirus complications. Heres how to stay safe. – NJ.com

Posted: Published on March 29th, 2020

The last time Sahar Hillel left the house beyond going to work or walking her dog was March 7. Even then, she wore blue latex lab gloves nearly everywhere she went. Continue reading

Posted in Coronary Heart Diseases | Comments Off on People with diabetes are at high risk for coronavirus complications. Heres how to stay safe. – NJ.com

Govt working on regulation to lower trans fats in foods – theindependentbd.com

Posted: Published on March 29th, 2020

The Bangladesh Food Safety Authority (BFSA) is working on a regulation that will bring trans-fats in food within a 2 per cent limit. This will help the country achieve the goal set by the World Health Organisation (WHO) to eliminate trans-fats from human food globally by 2023. Even though just three years are left to achieve the goal, Bangladesh is still far away from formulating any rules and regulations on trans fats in human food Continue reading

Posted in Coronary Heart Diseases | Comments Off on Govt working on regulation to lower trans fats in foods – theindependentbd.com

How Is Parkinson’s Disease Treated? | ParkinsonsDisease.net

Posted: Published on March 29th, 2020

Parkinsons disease (PD) is a chronic, progressive disease that affects the nerve cells in the brain and the body. It is not known exactly what causes the disease, although it is believed to be a combination of genetic and external factors. Current treatments alleviate the motor symptoms of PD. Continue reading

Posted in Parkinson's Treatment | Comments Off on How Is Parkinson’s Disease Treated? | ParkinsonsDisease.net

Parkinson’s Disease Treatment Market 2020 | Growing Rapidly with Significant CAGR, Leading Players, Innovative Trends and Expected Revenue by 2026 -…

Posted: Published on March 29th, 2020

New Jersey, United States:The Parkinsons Disease Treatment Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Continue reading

Posted in Parkinson's Treatment | Comments Off on Parkinson’s Disease Treatment Market 2020 | Growing Rapidly with Significant CAGR, Leading Players, Innovative Trends and Expected Revenue by 2026 -…

Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment -…

Posted: Published on March 29th, 2020

Study missed primary endpoint of mean time to conversion of SVT to SR over a five-hour period following dosing (p=0.12) Etripamil showed rapid conversion of SVT to SR during the first 45 minutes (p=0.02), consistent with its known pharmacology Study demonstrated a positive safety profile showing etripamil was well tolerated in the at-home setting Small number of placebo patients and prolonged efficacy measurement period confounded results Company plans to discuss next steps with regulators and continue its full PSVT clinical program, including NODE-301B, NODE-302 and NODE-303 Company to host conference call today at 5:00 p.m. ET MONTREAL and CHARLOTTE, N.C Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment -…

The Global Cardiac Safety Services Market is expected to grow from USD 419.45 Million in 2018 to USD 865.23 Million by the end of 2025 at a Compound…

Posted: Published on March 29th, 2020

March 25, 2020 18:35 ET | Source: ReportLinker New York, March 25, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cardiac Safety Services Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" - https://www.reportlinker.com/p05872122/?utm_source=GNW The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiac Safety Services Market including are Banook Group, Bioclinica, BioTelemetry, Inc., ERT, Inc., Labcorp, Biotrial, Celerion, Inc., Certara, L.P., IQVIA, Medpace, Ncardia, PhysioStim, Richmond Pharmacology, and Shanghai Medicilon Inc.. Continue reading

Posted in Cardiovascular Pharmacology | Comments Off on The Global Cardiac Safety Services Market is expected to grow from USD 419.45 Million in 2018 to USD 865.23 Million by the end of 2025 at a Compound…

Page 930«..1020..929930931932..940950..»